pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,542 catalysts · 5,539 phase readout · 2,261 8k filing · 230 earnings · 3 pdufa · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 0 catalysts2026-08-04: 0 catalysts2026-08-05: 18 catalysts2026-08-06: 12 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 2 catalysts2026-08-13: 2 catalysts2026-08-14: 1 catalyst2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 2 catalysts2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 1 catalyst2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 1 catalyst2026-10-14: 1 catalyst2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 2 catalysts2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 1 catalyst2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 2 catalysts2026-10-29: 5 catalysts2026-10-30: 3 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: phase readout×type: pdufa×type: recall×clear all
type
  • phase readout5,539
  • 8k filing2,261
  • earnings230
  • pdufa3
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

42
›WITHHELDphase readoutNCT06609265: [Trial of device that is not approved or cleared by the U.S. FDA]

Sponsor: [Redacted]. Phase: . Conditions:

full page →ctgov ↗
›COMPLETEDphase readoutNCT06154265: Intraoperative Echocardiography in Low-Risk CABG Surgery

Sponsor: University of Pennsylvania. Phase: NA. Conditions: Heart Diseases, Coronary Artery Disease, Chest Pain, Stenosis Coronary, STEMI

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504367: Large Language Models Assist in Tumor MDT

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University. Phase: NA. Conditions: Lung Cancer, Breast Cancer, Colorectal Cancer, Stomach Cancer, Liver Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07686367: Testing the Anti-Cancer Drug, Brenetafusp (IMCF106C), in Rare Cancers

Sponsor: National Cancer Institute (NCI). Phase: PHASE2. Conditions: Metastatic Myxoid Liposarcoma, Metastatic Synovial Sarcoma, Unresectable Myxoid Liposarcoma, Unresectable Synovial Sarcoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07340567: Personalizing Chemotherapy Selection After Surgery for Patients With Stage III Colorectal Cancer Using a Blood Test

Sponsor: UNICANCER. Phase: PHASE3. Conditions: Colorectal Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT05839600: A Study to Find a Suitable Dose of BI 1821736 and Test Whether it Helps People With Advanced Cancer

Sponsor: Boehringer Ingelheim. Phase: PHASE1. Conditions: Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT06872892: The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With Bronchiectasis

Sponsor: Boehringer Ingelheim. Phase: PHASE3. Conditions: Bronchiectasis

full page →ctgov ↗
›RECRUITINGphase readoutNCT07372911: PRoTECT: Corneal Wavefront Guided PRK + Epi-off CXL vs. PTK+Epi-off CXL in Keratoconus

Sponsor: Instituto de Oftalmología Fundación Conde de Valenciana. Phase: NA. Conditions: Keratoconus

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07719244: xDot Access Management System Pivotal Study

Sponsor: xDot Medical, Inc. Phase: NA. Conditions: Vascular Closure Devices

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07630844: REFRAME: an Emotion Regulation Intervention to Improve Psychological Outcomes in Surrogate Decision-Makers of the Critically Ill

Sponsor: Case Western Reserve University. Phase: NA. Conditions: Critical Illness

full page →ctgov ↗
›RECRUITINGphase readoutNCT07565844: Intradermal Exosomes, Platelet-Rich Plasma, and Steroids for Post-Herpetic Neuralgia

Sponsor: Zagazig University. Phase: NA. Conditions: Postherpetic Neuralgia ( PHN )

full page →ctgov ↗
›COMPLETEDphase readoutNCT02901444: Observational Study on Changing the Quality of Life in Daily Life Activities After Clinical Approach Positioning the Wheelchair

Sponsor: Centre Hospitalier Universitaire de Nīmes. Phase: . Conditions: Mobility Limitation, Wheelchairs

full page →ctgov ↗
›COMPLETEDphase readoutNCT07219134: Pilot Investigation of Dual Energy CT Imaging on an Online Adaptive Radiation Therapy System

Sponsor: University of Michigan Rogel Cancer Center. Phase: . Conditions: Genitourinary System Carcinoma, Malignant Pelvic Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT03025334: tDCS on Parkinson's Disease Cognition

Sponsor: University of Manitoba. Phase: NA. Conditions: Parkinson Disease, Mild Cognitive Impairment

full page →ctgov ↗
›COMPLETEDphase readoutNCT07581964: Effect of Sleep Apnea on Pain After Dental Treatment

Sponsor: Harran University. Phase: . Conditions: Obstructive Sleep Apnea, Postoperative Pain, Hypertension Complicated With Type 2 Diabetes

full page →ctgov ↗
›RECRUITINGphase readoutNCT05232032: Pharmaco-Neuroimaging Studies of Approach/Avoidance Behaviors and Post-Mortem Studies: Pharmacological Manipulation

Sponsor: Mclean Hospital. Phase: PHASE2. Conditions: Depressive Disorder, Major, Anxiety Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT02998398: Evaluation of the Switch From the Original Infliximab to Its Biosimilar in Daily Practice at Cochin Hospital

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Rheumatoid Arthritis, Spondyloarthritis, Crohn's Disease, Uveitis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07329998: The Aim of the Study is to Check Whether Follicular Fluid Evaluation Using a Spectrophotometer Can Differentiate High Quality Oocytes From Low Quality Oocytes. Oocyte Quality Will be Defined Using GDF9, BMP15 and Oocyte Morphology.

Sponsor: Hillel Yaffe Medical Center. Phase: NA. Conditions: Oocyte Quality Assessment Using Spectrophotometer

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT02653287: Lupus Intervention for Fatigue Trial

Sponsor: Northwestern University. Phase: NA. Conditions: Fatigue, Physical Activity, Lupus Erythematosus, Systemic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07503821: Synovial Tissue as a Biomarker in the Management of Pigmented Villonodular Synovitis

Sponsor: Nantes University Hospital. Phase: NA. Conditions: Synovitis Villonodular

full page →ctgov ↗
›RECRUITINGphase readoutNCT05677321: Individual Variations of Taste and Smell Perception in Alcohol Use Disorder (AUD)

Sponsor: National Institute on Alcohol Abuse and Alcoholism (NIAAA). Phase: . Conditions: Alcohol Use Disorder

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03012321: Abiraterone/Prednisone, Olaparib, or Abiraterone/Prednisone + Olaparib in Patients With Metastatic Castration-Resistant Prostate Cancer With DNA Repair Defects

Sponsor: Northwestern University. Phase: PHASE2. Conditions: Prostate Cancer Metastatic Castration-Resistant, Abnormal DNA Repair, Metastatic Prostate Carcinoma, Stage IV Prostate Cancer

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427914: Effectiveness and Safety of Benemix® in Constipation

Sponsor: Universidad de Antioquia. Phase: NA. Conditions: Constipation - Functional

full page →ctgov ↗
›RECRUITINGphase readoutNCT06075914: Ketone Conferred Resiliency Against Sleep Restriction With Nutritional Intervention.

Sponsor: Ohio State University. Phase: NA. Conditions: Sleep Deprivation, Nutritional Intervention

full page →ctgov ↗
›COMPLETEDphase readoutNCT01843504: Platelet-Rich Plasma (PRP) Injection for the Treatment of Chronic Patellar Tendinopathy

Sponsor: University of Wisconsin, Madison. Phase: PHASE2. Conditions: Chronic Patellar Tendinopathy, Chronic PT

full page →ctgov ↗
›COMPLETEDphase readoutNCT02158884: PRIORITI-MTF Study- Testing Patient Response to the IDEO

Sponsor: Major Extremity Trauma Research Consortium. Phase: NA. Conditions: Leg Injuries, Trauma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07399184: Effect of Perioperative IV Ibuprofen on Cerebral Oxygenation and Postoperative Cognition During One-Lung Ventilation

Sponsor: Ondokuz Mayıs University. Phase: NA. Conditions: Postoperative Delirium, Cerebral Oxygen Saturation, Postoperative Cognitive Dysfunction (POCD)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06829784: TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection

Sponsor: Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.. Phase: PHASE3. Conditions: Asthma

full page →ctgov ↗
›RECRUITINGphase readoutNCT07532733: Respiratory and Haemodynamic Effects of Conscious Sedation With Dexmedetomidine for a TAVI Procedure

Sponsor: Erasme University Hospital. Phase: NA. Conditions: TAVI(Transcatheter Aortic Valve Implantation)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07502352: Remotely-Delivered Cognitive Behavioral Stress Management for Breast Cancer (R-CBSM)

Sponsor: University of Miami. Phase: NA. Conditions: Breast Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06947538: Stepped Care for Posttraumatic Stress Disorder Study

Sponsor: Boston Medical Center. Phase: NA. Conditions: Post Traumatic Stress Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07350252: Combination of Nerve Blocks and Local Infiltration Analgesia in Knee Arthroplasty

Sponsor: Region Skane. Phase: PHASE4. Conditions: Osteo Arthritis of the Knee

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03770338: Preoperative Teriparatide Use on Insertional Torque of Pedicle Screws for Lumbar Fusion Surgery

Sponsor: The University of Hong Kong. Phase: NA. Conditions: Osteoporosis, Fusion of Spine, Lumbar Region

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06899958: Metabolism Enhancement by Laser Therapy

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Metabolism Disorder

full page →ctgov ↗
›RECRUITINGphase readoutNCT07664826: Acupuncture Mechanism in Relief of Gag Reflex

Sponsor: University Medicine Greifswald. Phase: NA. Conditions: Gag (Pharyngeal) Reflex

full page →ctgov ↗
›RECRUITINGphase readoutNCT05833555: Harlem Strong Mental Health Coalition

Sponsor: City University of New York, School of Public Health. Phase: NA. Conditions: Stress-related Problem, Depression, Anxiety, Mental Health Wellness

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05944926: Improving Outcomes in Depression in Primary Care in a Low Resource Setting

Sponsor: Harvard Medical School (HMS and HSDM). Phase: PHASE3. Conditions: Depression, Depressive Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT06702878: Light-Activated Antimicrobial Therapy to Prevent Surgical Site Infections

Sponsor: Ondine Biomedical Inc.. Phase: PHASE3. Conditions: Surgical Site Infections, Surgical Wound Infection, Infections, Anti-Infective Agents

full page →ctgov ↗
›RECRUITINGphase readoutNCT06446765: Mindfulness-based Neurofeedback to Augment Psychotherapy for Adults With Borderline Personality Disorder

Sponsor: Yale University. Phase: PHASE2. Conditions: Borderline Personality Disorder

full page →ctgov ↗
›COMPLETEDphase readoutNCT04188067: TMS for the Treatment of Primary Progressive Aphasia

Sponsor: Massachusetts General Hospital. Phase: NA. Conditions: Logopenic Variant Primary Progressive Aphasia, Non-fluent Variant Primary Progressive Aphasia, Semantic Variant Primary Progressive Aphasia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07374367: Isthmin-1 as a Biomarker of Disease Activity in Rheumatoid Arthritis: Correlation With Musculoskeletal Ultrasound Findings

Sponsor: Amera Imam Abdel - Ghany Ahmed. Phase: . Conditions: Disease Activity

full page →ctgov ↗
›RECRUITINGphase readoutNCT07696000: The Effect of Structured Medical Nutrition Therapy on Systemic Inflammation Index in Patients With Schizophrenia Receiving Antipsychotic Therapy

Sponsor: DINA KEUMALA SARI. Phase: NA. Conditions: Schizophrenia / Schizoaffective Disorder

full page →ctgov ↗
← prev
page 111 of 111
next →